We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Tax and reporting rules for employers providing medical or dental treatment and insurance
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
How to appeal if you disagree with a community treatment order (CTO) made by your responsible clinician.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
This form should be used to record that a patient has the capacity (or competence if under 16) to consent to treatment and that they have given consent.
Guidance on referring alcohol dependent patients from hospital to specialist alcohol treatment in the hospital or in the community.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Section (4A.01 - 4A.31) last updated October 2023.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
Self-assessment tool, good-practice examples and resources for community drug treatment services to help them deliver OST in line with clinical guidance.
Every local authority across England to be allocated additional funding to help combat drug and alcohol misuse.
Apply to become an approved authorised treatment facility (AATF) and how to operate legally under the approval.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).